business
Quadria-Backed Aragen Life Said to Plan $300 Million India IPO
Aragen Life Sciences Ltd., a contract research and manufacturing firm, is considering an initial public offering in Mumbai that could raise as much as $300 million, according to people familiar with the matter.
Read full story on Bloomberg Markets → More top storiesAlso covered by
Aggregated and edited by the Scoop newsroom. We surface news from Bloomberg Markets alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop